2026 NPPES data Gynecologic Oncology Physician NPI 1801978036 MD
Verify on CMS →

MICHAEL BEVERS, MD

Gynecologic Oncology Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
117
Medicare Part D claims · 47 beneficiaries · Gynecologic Oncology Physician avg: 188
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3897/100
▼ 2 pts below national avg 83.1 · [object Object]
What the federal data reveals: MICHAEL BEVERS, MD is a Gynecologic Oncology Physician ([object Object]) practicing in HOUSTON, Texas with a Medicare Part D prescribing footprint of 117 claims across 47 beneficiaries — 9% brand-name prescribing . Their CMS MIPS Final Score of 81.3897/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: MICHAEL BEVERS, MD reported a CMS MIPS final score of 81.3897 out of 100, below the 83.1 national average, and filed 117 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MICHAEL BEVERS, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MICHAEL BEVERS, MD at a glance

Near national average

NPI registry status

Active

Issued 10/19/2006

NPI 1801978036

Primary specialty

Gynecologic Oncology Physician

Niche

1,360 US NPIs in this specialty

Medicare Part D claims

117 38% vs specialty avg

2023 prescription claims

Specialty avg: 188

MIPS final score

81.3897/100 1.7102999999999895% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Gynecologic Oncology Physician compares to other specialties among Texas providers

Texas providers

Gynecologic Oncology Physician share within Texas

1. Gynecologic Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecologic Oncology Physician share within Texas

Medicare quality performance — MIPS

MICHAEL BEVERS, MD's 2023 MIPS final score plotted against the Gynecologic Oncology Physician national average

Near national average
MIPS Final Score
81.3897/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Gynecologic Oncology Physician) — 81.3897/100 vs national avg 83.1

0%100%National avg83%81.4%
MIPS final score (Gynecologic Oncology Physician) — 81.3897/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL BEVERS, MD is a Gynecologic Oncology Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1801978036. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL BEVERS, MD appears in the CMS NPPES registry as a Gynecologic Oncology Physician provider holding MD credentials at 1515 HOLCOMBE BLVD, HOUSTON, TX, 77030, with a listed phone of (713) 792-6161. NPI 1801978036 was issued on 10/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BEVERS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 117 prescription claims written by this provider, covering 47 Medicare beneficiaries and totaling roughly $7K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3897/100 for the 2023 performance year (Quality 81.2519, Cost 49.9786), compared with the national average of 83.1.

Gynecologic Oncology Physician is a narrow specialty nationwide, with 1,360 enrolled providers across 49 states and an average of 188 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1515 HOLCOMBE BLVD
HOUSTON, TX 77030

Provider Details

NPI 1801978036
Specialty Gynecologic Oncology Physician
Credentials MD
Gender Male
NPI Issued 10/19/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.3897
Final Score
Avg: 83.1
81.2519
Quality
49.9786
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MICHAEL BEVERS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PHYSICIANS REFERRAL SERVICE
HOUSTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MICHAEL BEVERS, MD. To verify MICHAEL BEVERS, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MICHAEL BEVERS, MD — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 117 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

117
Total Claims
$7K
Total Drug Cost
47
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
134
Total Day Supply
2,549
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$5K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
1.68
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ondansetron Hcl
17
Prochlorperazine Maleate
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecologic Oncology Physician Overview

How MICHAEL BEVERS, MD fits within the Gynecologic Oncology Physician landscape nationally.

1,360
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
188
Avg Claims per Provider

MICHAEL BEVERS, MD's 117 claims are below the specialty average of 188.

Nearby Gynecologic Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BEVERS.

Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL BEVERS, MD's specialty?
MICHAEL BEVERS, MD specializes in Gynecologic Oncology Physician and practices in HOUSTON, Texas. Credentials: MD.
How much does MICHAEL BEVERS, MD prescribe under Medicare Part D?
In 2023, MICHAEL BEVERS, MD wrote 117 Medicare Part D claims totaling $7K in drug costs for 47 beneficiaries.
What is MICHAEL BEVERS, MD's Medicare quality score?
MICHAEL BEVERS, MD has a CMS MIPS Final Score of 81.3897/100 (Quality: 81.2519, Cost: 49.9786). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL BEVERS, MD located?
MICHAEL BEVERS, MD is located at 1515 HOLCOMBE BLVD, HOUSTON, TX, 77030. Phone: (713) 792-6161.
What is MICHAEL BEVERS, MD's NPI number?
MICHAEL BEVERS, MD's National Provider Identifier (NPI) is 1801978036, issued on 10/19/2006.
Does MICHAEL BEVERS, MD prescribe more brand-name or generic drugs?
MICHAEL BEVERS, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $5K in brand drug costs.
How many Gynecologic Oncology Physician providers are there in the US?
There are 1,360 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 188 Medicare Part D claims per year.
What drugs does MICHAEL BEVERS, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL BEVERS, MD's most frequently prescribed drugs include Ondansetron Hcl, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL BEVERS, MD accept Medicare?
MICHAEL BEVERS, MD appears in CMS Medicare data with 117 Part D claims and 47 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL BEVERS, MD's credentials?
MICHAEL BEVERS, MD's NPI is 1801978036 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology